patent/JP-2009518393-A

Predicate	Object
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
filingDate	2006-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	JP-2009518393-A
titleOfInvention	Dioxolane derivatives for cancer treatment
abstract	The present invention relates to certain unsaturated fatty acid derivatives of therapeutically active 1,3-dioxolane nucleoside analogs and pharmaceutical formulations containing them. Here, the derivative is referred to as “compound of formula (I)”. The compounds of formula (I) can be used in the treatment of cancerous diseases. Treatment of both solid tumors and blood cancers (leukemia, lymphoma, multiple myeloma, etc.). [Chemical 1]
priorityDate	2005-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004510832-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09504785-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003225037-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10506385-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467615800

Total number of triples: 23.